Scientific Vita
Con­tact
Info

Prof. Dr.

Ulrich Lauer

Project: C07

Academic Education and Scientific Degrees
2009
Board Certification in Infectious Diseases
2007
Diploma of the European Board of Gastroenterology
2007
Certification in Gastrointestinal Oncology (German Gastroenterological Association, DGVS)
2005
Board Certification in Gastroenterology
2005
Board Certification in Laboratory Investigations in Internal Medicine
2001
Venia Legendi (Habilitation), Internal Medicine (supervised by Prof. Dr. M. Gregor, Eberhard-Karls-University Tübingen)
2000
Board Certification Internal Medicine
1989
Doctor of Medicine, University of Erlangen-Nürnberg (supervised by Prof. Dr. J.R. Kalden)
1988
Medical Approbation, State of Bavaria
1982-1988
Study of Medicine, University of Erlangen-Nürnberg

Professional Career
2016-present
Deputy Director of Internal Medicine VIII
2006
Associate Professor of the Medical Faculty, Eberhard-Karls-University Tübingen
2001-present
Consultant in Internal Medicine (Oberarzt), Dept. of Gastroenterology, Hepatology, and Infectious Diseases, University Hospital Tübingen
1993-2000
Fellow in Internal Medicine (Dept. of Gastroenterology, Hepatology, and Infectious Diseases, University Hospital Tübingen)
Since 1993
Research group leader (Gene Therapy / Virotherapy)
1988-1993
Postdoctoral Research Fellow, Max-Planck-Institute for Biochemistry, Dept. of Virus Research (Head: Prof. Dr. Dr. H. Hofschneider), Martinsried, Germany
Address
Clinical Tumorbiology & Phase I Clinic
University Hospital and Eberhard-Karls-University Tübingen
Otfried-Müller-Str. 10
72076 Tübingen
Phone
+49/7071/298 3190
eMail
Ulrich.Lauer@uni-tuebingen.de
Awards and Appointments
2014
Teaching Award of the Medical Faculty, Eberhard-Karls-University Tübingen: Best Lecturer of the Year
2011
Award from the State of Baden-Württemberg, Germany for “Alternative & Complementary Methods to Animal Experimentation”
2005
Novartis Award for Research, 18th International Symposium on Pediatric Surgical Research
2005
Award from the Southwest-German Society of Internal Medicine
2000
Lecture Award of the Medical Faculty, Eberhard-Karls-University Tübingen
1999
Junior Research Group Leader of the IZKF Tübingen (Interdisciplinary Center for Clinical Research)
1994
Award from the Sandoz-Stiftung for Therapeutic Research

Others
2014
Head of “Tübingen Virotherapy Center”
2012-2014
Protocol development and PI of the first German clinical virotherapy trial (at University Hospital Tübingen) employing a recombinant oncolytic virus: “Phase I/II study of intraperitoneal administration of GL-ONC1, a genetically modified vaccinia virus, in patients with peritoneal carcinomatosis (EudraCT no: 2010-022680-35; first patient in: 04/2012)”
2013-present
Member of the Task Force Technology Transfer of the Medical Faculty of the Eberhard-Karls-University Tübingen and the University Hospital Tübingen
2012-present
Member of the Ethics Committee of the Medical Faculty of the Eberhard-Karls- University Tübingen and the University Hospital Tübingen
2011-present
Executive Board of the German Virotherapy Consortium (GVC) 2006-present Head of the German Oncolysis Consortium (GOC)

Patents
“Oncolytic measles virus”, EP2605783 (granted 25.03.2015), US9272008 B2 (granted 01.03.2016), JP6001535 (granted 09.09.2016)
“Genetically modified paramyxoviruses for the treatment of tumor diseases”, DE 102010018961, (granted 20.09.2012).